Thompson Siegel & Walmsley’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,400
Closed -$3K 786
2019
Q2
$3K Buy
+2,400
New +$2.75K ﹤0.01% 714
2019
Q1
Sell
-2,400
Closed -$2K 784
2018
Q4
$2K Hold
2,400
﹤0.01% 732
2018
Q3
$3K Hold
2,400
﹤0.01% 743
2018
Q2
$4K Hold
2,400
﹤0.01% 763
2018
Q1
$3K Hold
2,400
﹤0.01% 768
2017
Q4
$3K Hold
2,400
﹤0.01% 802
2017
Q3
$2K Hold
2,400
﹤0.01% 820
2017
Q2
$2K Hold
2,400
﹤0.01% 799
2017
Q1
$2K Hold
2,400
﹤0.01% 791
2016
Q4
$2K Hold
2,400
﹤0.01% 796
2016
Q3
$2K Hold
2,400
﹤0.01% 707
2016
Q2
$4K Hold
2,400
﹤0.01% 690
2016
Q1
$6K Hold
2,400
﹤0.01% 639
2015
Q4
$6K Hold
2,400
﹤0.01% 649
2015
Q3
$5K Hold
2,400
﹤0.01% 665
2015
Q2
$5K Hold
2,400
﹤0.01% 657
2015
Q1
$4K Hold
2,400
﹤0.01% 671
2014
Q4
$5K Hold
2,400
﹤0.01% 666
2014
Q3
$6K Hold
2,400
﹤0.01% 653
2014
Q2
$6K Hold
2,400
﹤0.01% 624
2014
Q1
$7K Hold
2,400
﹤0.01% 614
2013
Q4
$12K Sell
2,400
-49,400
-95% -$279K ﹤0.01% 563
2013
Q3
$285K Hold
51,800
0.01% 368
2013
Q2
$377K Buy
+51,800
New +$441K 0.01% 353

Thompson Siegel & Walmsley's IMI Position: Q3 2019 in Review

Thompson Siegel & Walmsley sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 2,400 shares — an estimated $3K sold.

Thompson Siegel & Walmsley first reported a position in IMI in Q2 2013 and held it in 24 quarters. The position peaked at $377K in Q2 2013. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.

  • Thompson Siegel & Walmsley reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,400 Intermolecular, Inc. shares in Q3 2019, an estimated $3K.
  • Thompson Siegel & Walmsley first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 24 quarters.
  • Thompson Siegel & Walmsley's Intermolecular, Inc. position peaked at $377K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2019, filed 12 Nov 2019.